Xin Lang Cai Jing·2025-11-07 01:36Group 1 - On November 6, BeiGene's stock rose by 2.67%, with a trading volume of 767 million yuan [1] - The financing data for BeiGene on the same day showed a financing purchase amount of 88.91 million yuan and a financing repayment of 108 million yuan, resulting in a net financing outflow of 19.39 million yuan [1] - As of November 6, the total margin balance for BeiGene was 1.317 billion yuan, with a financing balance of 1.298 billion yuan, accounting for 4.07% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - As of June 30, the number of BeiGene shareholders was 23,300, a decrease of 3.90% from the previous period, while the average circulating shares per person increased by 4.11% to 4,976 shares [2] - For the first half of 2025, BeiGene reported a revenue of 17.518 billion yuan, representing a year-on-year growth of 46.03%, and a net profit attributable to shareholders of 450 million yuan, up 115.63% year-on-year [2] - Among the top ten circulating shareholders as of June 30, 2025, China Europe Medical Health Mixed A ranked fourth with 4.8254 million shares, an increase of 1.2436 million shares from the previous period [2]